Skip to main content

Table 1 Demographic Data of the Teriparatide and Control Groups

From: Effects of teriparatide on cementless bipolar hemiarthroplasty in patients with osteoporotic femoral neck fractures

Parameters Group A Group B p value
N = 52 N = 40
Variables
Age at time of operation (yrs) 71.0 ± 8.3 72.1 ± 7.6 0.682
Body mass index (kg/m2) 26.9 ± 2.5 25.9 ± 3.1 0.693
ASA classification    0.829
 ASA I - - -
 ASA II 33 (63.5 %) 24 (60.0 %)  
 ASA III 19 (36.5 %) 16 (40.0 %)  
Hospital stay (day) 7.3 ± 1.6 6.9 ± 1.6 0.464
BMD of contralateral hip (T-score) −4.3 ± 1.2 −4.2 ± 1.0 0.908
Femoral stem-canal ratio (%) 88.3 ± 5.2 87.6 ± 5.3 0.620
Follow-up (months) 27.1 ± 7.3 26.2 ± 7.4 0.650
  1. Group A: patients without supplementary pharmacologic treatment
  2. Group B: patients treated with teriparatide
  3. Values are shown as mean (standard deviation) or as the n (%)
  4. p-values for between-group comparisons were determined by the chi-squared test and Fisher’s exact test for categorical variables and Student’s t test for continuous variables
  5. *Statistically significant (p < 0.05)